MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
October 14, 2020

ESMO: Late-Line Ripretinib Offers Clinical Benefit in Gastrointestinal Stromal Tumors

By Michael Vlessides, /alert Contributor
The switch-control tyrosine kinase inhibitor ripretinib (Qinlock; Deciphera Pharmaceuticals, Inc.) offers clinical benefit as fourth-line treatment in patients with advanced gastrointestinal stromal tumors...
ESMO: Late-Line Ripretinib Offers Clinical Benefit in Gastrointestinal Stromal Tumors
September 17, 2020

ESMO 2020 Congress Highlights Impact of COVID-19 on Cancer Care

By Adam Hochron
At the opening press conference of  the ESMO 2020 Congress, presenters from around Europe and Asia looked at the impact of the COVID-19 pandemic that forced the in-person meeting to be shifted online...
ESMO 2020 Congress Highlights Impact of COVID-19 on Cancer Care
September 16, 2020

Discontinuation of Digoxin Remains Risky in Heart Failure Patients

By Brenda L. Mooney /alert Contributor
For decades, clinicians have been aware that discontinuing digoxin increased the risk for worsening symptoms in patients with chronic heart failure...
Discontinuation of Digoxin Remains Risky in Heart Failure Patients
September 15, 2020

Hair Dye Dose Potentially Associated With Breast, Ovarian Cancer Risk

By Michael Vlessides, /alert Contributor

Although new research has found no association between personal use of permanent hair dye and the risk of most cancers or cancer-related mortality, the study found a potential link between what they call ‘cumulative dose’ of hair dye and certain types of breast cancer...
Hair Dye Dose Potentially Associated With Breast, Ovarian Cancer Risk
September 11, 2020

Study Examined Evinacumab for Homozygous Familial Hypercholesterolemia

By Adam Hochron
Following previous research showing Evinacumab, a monoclonal antibody, having benefits in treating homozygous familial hypercholesterolemia...
Study Examined Evinacumab for Homozygous Familial Hypercholesterolemia
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

REFILE-Per-oral endoscopic myotomy "reasonable" first-line treatment for idiopathic achalasia

(Corrects spelling of researcher's name, to Mundre, in paras 2 and 4 of Oct 19 story.) By Marilynn Larkin NEW YORK (Reuters Health) - Per-oral endoscopic myotomy (POEM) has comparable efficacy to Read More »

Local estrogen therapy for vaginal atrophy can start before or after age 60

By Marilynn Larkin NEW YORK (Reuters Health) - Treatment with low-dose local estrogen therapy (ET) to improve symptoms of vaginal atrophy may start before or after age 60, according to a post-hoc Read More »

DVT screening, early treatment, prevent PE in necrotizing pancreatitis

By Marilynn Larkin NEW YORK (Reuters Health) - Ultrasound screening enabled identification and early treatment of extremity deep vein thrombosis (DVT), thereby preventing symptomatic pulmonary Read More »

Women with cervical cancer at increased risk of injury during diagnostic workup

By Linda Carroll (Reuters Health) - Among the women who were screened for cervical cancer in Sweden, those with invasive cancer and carcinoma in situ were at increased risk of injury associated with Read More »

U.S. likely to have enough COVID-19 vaccines for all vulnerable Americans by year end -official

By Carl O'Donnell (Reuters) - The United States is likely to have enough safe and effective COVID-19 vaccines available to inoculate the most vulnerable Americans by the end of 2020, Health and Human Read More »

UPDATE 1-OxyContin maker Purdue reaches plea deal in opioid probe

(Adds details, background, that Sacklers propose ceding control of Purdue) By Mike Spector NEW YORK (Reuters) - Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its Read More »

Frailty, advanced age tied to less time at home after cancer resection

By Lisa Rapaport (Reuters Health) - Elderly, frail and low-income adults may have less time at home after cancer resection than patients who are younger and more affluent, a Canadian study suggests. Read More »

UPDATE 1-AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue

(Adds source comment on volunteer not being in active trial) By Eduardo Simões and Ricardo Brito SAO PAULO/BRASILIA (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information